New Delhi: Ophthalmologists across India are urging the central government to include advanced treatments for diabetic retinopathy under Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY), the ...

– Susvimo can help people with diabetic retinopathy (DR) maintain their vision and prevent progression to blindness with only one treatment every nine months – – Susvimo’s innovative technology via ...

High blood sugars have long been known to cause eye damage in diabetics. However, new research has found that low blood sugar may also contribute. The good news is that it also identified a way of ...

Researchers identify the protein LRG1, which is present in the body, as a trigger of early retinal damage in diabetic ...

Ophthalmologist , Vitreoretinal Surgeon, talks about how diabetic retinopathy is caused in patients with diabetes as well as treatment and management strategies. Kevin Spacey Says He's Homeless and ...

Empagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, did not reduce the risk for incident nonproliferative diabetic retinopathy compared with dipeptidyl peptidase 4 (DPP-4) inhibitors in ...

Roche said its Susvimo drug received approval from the U.S. drug regulator for the treatment of diabetic retinopathy, a potentially blinding condition. Susvimo can help people with diabetic ...

Diabetic eye disease is a leading cause of vision loss in individuals aged 20 to 74,(3) and diabetic macular edema (DME), left untreated, is the leading cause of blindness in diabetic patients. The ...

The goal of systemic management of risk factors (glucose, blood pressure and lipid control) is to prevent diabetic retinopathy (DR) incidence or progression to vision-threatening DR. The greatest ...